A reduction in SRSF3 expression has been noted in both human and mouse liver tissues affected by MASLD, MASH, and HCC [81,82], leading to altered splicing of SFRS3-regulated genes. The gene discussed is SRSF3; the disease is hepatocellular carcinoma.